STO-609 acetateSelective CaM kinase kinase inhibitor CAS# 1173022-21-3 |
- Gimeracil
Catalog No.:BCC2296
CAS No.:103766-25-2
- Isosafrole
Catalog No.:BCC3976
CAS No.:120-58-1
- Mycophenolate Mofetil
Catalog No.:BCC2290
CAS No.:128794-94-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1173022-21-3 | SDF | Download SDF |
PubChem ID | 16760660 | Appearance | Powder |
Formula | C21H14N2O5 | M.Wt | 374.35 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 45 mM in 100mM NaOH and to 10 mM in DMSO with sonication | ||
SMILES | CC(=O)O.C1=CC=C2C(=C1)N=C3N2C(=O)C4=CC=CC5=C(C=CC3=C54)C(=O)O | ||
Standard InChIKey | WNRSTFUVBWNELX-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C19H10N2O3.C2H4O2/c22-18-13-5-3-4-10-11(19(23)24)8-9-12(16(10)13)17-20-14-6-1-2-7-15(14)21(17)18;1-2(3)4/h1-9H,(H,23,24);1H3,(H,3,4) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Selective, cell-permeable inhibitor of Ca2+-calmodulin-dependent protein kinase kinase (Ki values are 80 and 15 ng/ml for inhibition of CaM-KKα and CaM-KKβ respectively); competes for the ATP-binding site. Displays > 80-fold selectivity over CaMK1, CaMK2, CaMK4, MLCK, PKC, PKA and p42 MAPK. |
STO-609 acetate Dilution Calculator
STO-609 acetate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6713 mL | 13.3565 mL | 26.713 mL | 53.4259 mL | 66.7824 mL |
5 mM | 0.5343 mL | 2.6713 mL | 5.3426 mL | 10.6852 mL | 13.3565 mL |
10 mM | 0.2671 mL | 1.3356 mL | 2.6713 mL | 5.3426 mL | 6.6782 mL |
50 mM | 0.0534 mL | 0.2671 mL | 0.5343 mL | 1.0685 mL | 1.3356 mL |
100 mM | 0.0267 mL | 0.1336 mL | 0.2671 mL | 0.5343 mL | 0.6678 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- RS 102895 hydrochloride
Catalog No.:BCC7260
CAS No.:1173022-16-6
- gamma-secretase modulator 1
Catalog No.:BCC1583
CAS No.:1172637-87-4
- 8alpha-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate
Catalog No.:BCN1609
CAS No.:117254-98-5
- Soyasaponin Aa
Catalog No.:BCN2597
CAS No.:117230-33-8
- Taxacin
Catalog No.:BCN6950
CAS No.:117229-54-6
- HO-3867
Catalog No.:BCC5639
CAS No.:1172133-28-6
- PI3Kγ inhibitor 1
Catalog No.:BCC4180
CAS No.:1172118-03-4
- M 1145
Catalog No.:BCC6053
CAS No.:1172089-00-7
- Sophoraisoflavone A
Catalog No.:BCN6826
CAS No.:117204-81-6
- Boc-Ala(3-pyridyl)-OH
Catalog No.:BCC3322
CAS No.:117142-26-4
- Fmoc-N-Me-Thr(tBu)-OH
Catalog No.:BCC3354
CAS No.:117106-20-4
- Fmoc-Thr(tBu)-OPfp
Catalog No.:BCC3553
CAS No.:117088-31-0
- GW 583340 dihydrochloride
Catalog No.:BCC7300
CAS No.:1173023-85-2
- U0126-EtOH
Catalog No.:BCC1066
CAS No.:1173097-76-1
- PKI-402
Catalog No.:BCC3843
CAS No.:1173204-81-3
- Clocinnamox mesylate
Catalog No.:BCC5684
CAS No.:117332-69-1
- Emeheterone
Catalog No.:BCN7285
CAS No.:117333-12-7
- 9,9-Bis[4-(2-hydroxyethoxy)phenyl]fluorene
Catalog No.:BCC8796
CAS No.:117344-32-8
- 2-Hydroxysaclofen
Catalog No.:BCC6579
CAS No.:117354-64-0
- AZD6482
Catalog No.:BCC2523
CAS No.:1173900-33-8
- Endothelin 3 (human, rat)
Catalog No.:BCC5713
CAS No.:117399-93-6
- Artoheterophyllin B
Catalog No.:BCN6050
CAS No.:1174017-37-8
- Dimethylwulignan A1
Catalog No.:BCN3624
CAS No.:117404-43-0
- AZD2461
Catalog No.:BCC2214
CAS No.:1174043-16-3
STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase.[Pubmed:11867640]
J Biol Chem. 2002 May 3;277(18):15813-8.
STO-609, a selective inhibitor of Ca(2+)/calmodulin-dependent protein kinase kinase (CaM-KK) was synthesized, and its inhibitory properties were investigated both in vitro and in vivo. STO-609 inhibits the activities of recombinant CaM-KK alpha and CaM-KK beta isoforms, with K(i) values of 80 and 15 ng/ml, respectively, and also inhibits their autophosphorylation activities. Comparison of the inhibitory potency of the compound against various protein kinases revealed that STO-609 is highly selective for CaM-KK without any significant effect on the downstream CaM kinases (CaM-KI and -IV), and the IC(50) value of the compound against CaM-KII is approximately 10 microg/ml. STO-609 inhibits constitutively active CaM-KK alpha (glutathione S-transferase (GST)-CaM-KK-(84-434)) as well as the wild-type enzyme. Kinetic analysis indicates that the compound is a competitive inhibitor of ATP. In transfected HeLa cells, STO-609 suppresses the Ca(2+)-induced activation of CaM-KIV in a dose-dependent manner. In agreement with this observation, the inhibitor significantly reduces the endogenous activity of CaM-KK in SH-SY5Y neuroblastoma cells at a concentration of 1 microg/ml (approximately 80% inhibitory rate). Taken together, these results indicate that STO-609 is a selective and cell-permeable inhibitor of CaM-KK and that it may be a useful tool for evaluating the physiological significance of the CaM-KK-mediated pathway in vivo as well as in vitro.